LUCENTIS NEWS HIGHLIGHTS Media Articles Related to Lucentis (Ranibizumab)
Ranibizumab Injections Reduce Retinal Swelling
Source: MedicineNet Edema Specialty [2008.05.02]
Gene Linked to 'Dry' Macular Degeneration
Source: MedicineNet Macular Degeneration (Age-Related Type) Specialty [2008.08.28]
Macular Degeneration (Age-Related Type)
Source: MedicineNet Eyeglasses, Sunglasses, and Magnifiers Specialty [2007.12.27]
Brain Reorganizes To Adjust For Loss Of Vision
Source: Eye Health / Blindness News From Medical News Today [2008.11.21]
Published Studies Related to Lucentis (Ranibizumab)
Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions. [2008.10]
Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. [2007.10]
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. [2007.02]
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. [2006.11]
Ranibizumab versus verteporfin for neovascular age-related macular degeneration. [2006.10.05]
Clinical Trials Related to Lucentis (Ranibizumab)
Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema [Recruiting]
Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-Related Macular Degeneration (AMD) [Recruiting]
Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-Based Retreatment [Recruiting]
Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration [Not yet recruiting]
Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization [Recruiting]
|
